NCT03568149

Brief Summary

The pelvic congestion syndrome (PCS) is a complex and multifactorial condition associated with inflammatory and hormonal etiophatogenesis similar to the endometriosis. Furthermore, both pathologies share same clinical symptoms as chronic pelvic pain and dyspareunia. Our hypothesis is that PCS prevalence is higher in patients with endometriosis than in those without clinical or ultrasound signs of endometriosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

December 14, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

June 12, 2019

Status Verified

June 1, 2019

Enrollment Period

7 months

First QC Date

June 11, 2018

Last Update Submit

June 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of pelvic congestive syndrome in patients with endometriosis

    Comparison of pelvic congestive syndrome symptoms and ultrasounds characteristics, assessed by standard gynecological examination (bimanual gynecological examination and gynecological ultrasounds), between patients with endometriosis (Group A) and without clinical or ultrasound signs of endometriosis.

    1 day, first medical examination

Secondary Outcomes (4)

  • Correlation between type of pain and pelvic congestive syndrome

    1 day, first medical examination

  • Correlation between pain severity and pelvic congestive syndrome

    1 day, first medical examination

  • Correlation between symptoms and ongoing medical treatments

    1 day, first medical examination

  • Correlation between history of pelvic surgery and pelvic congestive syndrome

    1 day, first medical examination

Study Arms (2)

Group A: endometriosis

assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.

Procedure: assessment of pain symptoms at first medical examinationProcedure: assessment of pelvic vascular insufficiency signs

Group B: no endometriosis

assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.

Procedure: assessment of pain symptoms at first medical examinationProcedure: assessment of pelvic vascular insufficiency signs

Interventions

First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

Group A: endometriosisGroup B: no endometriosis

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters: * Ovarian vein diameter \<4mm * Slow ovarian blood flow (\<3cm/sec) * Retrograde blood flow * Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious This evaluation includes the study of uterine and ovarian vessels, using different techniques: * Standard 2D study, to measure vessels diameter * Vascular doppler study, to evaluate flow direction and blood speed * 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.

Group A: endometriosisGroup B: no endometriosis

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing routine gynecological examinations in our center are included in the study.

You may qualify if:

  • Obtaining Informed Consent
  • Nulliparity
  • Clinical or ultrasounds signs of endometriosis
  • Obtaining Informed Consent
  • Nulliparity

You may not qualify if:

  • Menopause
  • Actual or previous pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital

Bologna, BO, 40138, Italy

RECRUITING

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 11, 2018

First Posted

June 26, 2018

Study Start

December 14, 2018

Primary Completion

July 1, 2019

Study Completion

August 1, 2019

Last Updated

June 12, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations